| Labatec Pharma SA - Ovaleap 450 IU/0.75 ml, solution injectable |
| 66255 | | 02 | | Ovaleap 450 IU/0.75 ml | | solution injectable | | G03GA05 | | Follitropin alfa | | 28.08.2018 | | |
|
| Composition |
| follitropinum alfa 450 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, methioninum, polysorbatum 20, alcohol benzylicus 7.5 mg, benzalkonii chloridum 0.015 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.75 ml corresp. natrium 7.7 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Follitropine Alfa | 450U.I. / 0.75ml |
| | BAG: Principe actif | Concentr. |
|---|
| Follitropine Alfa | 450 UI |
| | | | Agents auxilliaires | Concentr. |
|---|
| Alcohol Benzylicus | 7.5mg / 0.75ml | | Benzalkonium Chlorure | 0.015mg / 0.75ml | | Mannitol | | | Methionine | | | Sodium Dihydrogenophosphate Dihydrate | | | Natrii Hydroxidum ad Ph | | | Polysorbatum 20 | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | | 138.12 | 166.65 | A | LS | Non |
|
